First Solar's Cloudy Future Without subsidies, First Solar would be in trouble.
How MARA Holdings Stock Gained 16% Last Month Is MARA Holdings winning the Bitcoin mining race? Check out its recent numbers and decide for yourself.
Investor Rights In A Margin "Blowout" What are an investor’s legal rights when a brokerage firm seeks to liquidate a portfolio with margin in a rapidly declining market? The answer is, it's complicated.
Fed Meeting: Rate-Cut Odds Fading, But Powell May Surprise S&P 500 Federal Reserve Chairman Jerome Powell helped sink the S&P 500 with a hawkish spin on Trump tariffs, but he may surprise on Wednesday.
MultiversX Under the Hood: VeroPay’s Secret Sauce VeroPay fuses NFC, blockchain, and real-time analytics to overhaul payments and logistics at large-scale events.
Palantir Stock Plummets As Analysts Flag Valuation Risks Despite Q1 Revenue Beat Analysts warn that while Palantir's execution is impressive, concerns remain that its stock trades at a valuation difficult to justify without further acceleration.
Will Gold’s Recovery Take Metal To New Highs? After rallying sharply on Monday, gold got another shot in the arm during the first half of Tuesday’s session.
Ferrari Q1 Profit Zooms 17% But Trump Tariffs Cloud 2025 Forecast The sports car maker posted a net profit of €412 million (approximately $466 million) during the quarter, growing 17% year over year.
Tesla Stock Slips Amid European Sales Drop, Cybertruck Inventory Build Tesla stock is trading lower amid reports that new car sales in the U.K. and Germany hit two-year lows.
TopBuild Q1 Sales Dip, EPS Tops Estimates, Seal-Rite Deal Boosts Long-Term Outlook, Guidance Reaffirmed TopBuild Corp. (
NYSE: BLD ) reported Q1 2025 sales of $1.23 billion in line with expectations. Sales declined 3.6% YoY, adjusted gross margin and EPS also dropped but remain optimistic about future prospects. BLD shares up 1.67% at $296.87.
Neurocrine Biosciences Surges On 'Surprising' Momentum For Its Newest Drug The company reported a strong start for its newest drug, Crenessity, which treats a hormonal disorder involving the adrenal glands.
WeRide (WRD) Stock Gains 5% Amid Expansion with Uber WeRide shares surged 5.9% during Tuesday's trading session. The autonomous driving company announced a global expansion of its partnership with Uber.
Bessent Signals Imminent Trade Deals, Dismisses Recession Fears As Stocks Rebound Treasury Sec. Bessent defended Trump admin's economic policy, praising job gains & trade deals. 90% of renegotiations expected by year-end.
